Lallemand launches Cerebiome to support stress by way of gut-brain axis
Previously known as Probio’Stick, Lallemand’s Cerebiome showcases the product’s effect on the gut-brain axis, referring to it as a “psychobiotic.”
Photo © iStockphoto.com/adventtr
Lallemand Health Solutions (Mirabel, Canada) has rebranded an existing formula consisting of Lactobacillus helveticus Rosell-52 and Bifidobacterium longum Rosell-175 to Cerebiome. Previously known as Probio’Stick, Lallemand’s Cerebiome showcases the product’s effect on the gut-brain axis, referring to it as a “psychobiotic.”
“Cerebiome is a unique and strongly documented psychobiotic formulation developed by the Rosell Institute for Microbiome and Probiotics by Lallemand,” explains Lucie Lingrand, Product Manager at Lallemand Health Solutions, in a press release. “It is the most documented psychobiotic with five clinical studies and several pre-clinical studies allowing to highlight eight mechanisms of action on the brain-gut axis. Cerebiome helps alleviate the physical and psychological symptoms of stress and feelings of anxiety. Such consistency of results is rare in this innovative field.”
Judge in CRN’s complaint against NY denies the State’s motion to dismiss
May 14th 2024New York State's motion to dismiss CRN's lawsuit against the law banning the sale of weight management and muscle-building supplements to minors has been partially denied, allowing CRN to proceed with its First Amendment Claim.
